Pulmatrix, Inc.
Pharmaceutical company · Framingham, Massachusetts, United States · Nasdaq: PULM
Pulmatrix, Inc. is a pharmaceutical company headquartered in Framingham, Massachusetts, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker PULM. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2026.
Pulmatrix at a glance
What does Pulmatrix do?
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $1 million sold (2026).
Frequently asked questions about Pulmatrix
Where is Pulmatrix headquartered?
Pulmatrix, Inc. is headquartered in Framingham, Massachusetts, United States.
What does Pulmatrix do?
Pulmatrix, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Pulmatrix a public company?
Yes. Pulmatrix, Inc. trades on Nasdaq under the ticker PULM.
When was Pulmatrix founded?
The earliest incorporation on record for Pulmatrix, Inc. is in 2013, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.